All stock lists
Franco-Nevada Corporation (New York Stock Exchange:FNV)
CA · Delayed Price · Currency is USD
Also listed: FNV.TO, 0QYZ.LBasic Materials · Gold
255.79-7.67 (-2.91%)
Market cap
$49.3B
Insider Score
Health Score
Analyst consensus
Listed since
Dec 3, 2007
Website
Insider Score
––Not scored
FNV Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From FNV’s reported statements · Q2 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $2.32B
- Net income
- $1.48B
- Net margin
- 63.8%
Leverage20 / 20
Little or no net debt.
- Total debt
- $0
- Cash
- $1.01B
- Net debt / EBITDA
- -0.46x
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $1.39B
- Current liabilities
- $148.0M
- Current ratio
- 9.38
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $1.78B
- Free cash flow
- $891.4M
- FCF margin
- 38.5%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 193.3M
- Share growth (1y)
- 0.3%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
FNV Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 580.90 M | 650.70 M | 597.30 M | 487.70 M | 369.40 M | 368.40 M |
| Revenue Growth (YoY) | 57.26 % | 76.63 % | 86.07 % | 76.90 % | 42.02 % | 43.46 % |
| Cost of Revenue | 129.90 M | 124.40 M | 136.90 M | 134.20 M | 97.50 M | 106.90 M |
| Gross Profit | 451.00 M | 526.30 M | 460.40 M | 353.50 M | 271.90 M | 261.50 M |
| SG&A Expense | 7.80 M | 15.40 M | 2.60 M | 16.30 M | 8.50 M | 15.10 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 5.30 M | 15.40 M | 2.60 M | 16.30 M | 8.50 M | 15.10 M |
| Operating Income | 445.70 M | 510.90 M | 457.80 M | 337.20 M | 263.40 M | 246.40 M |
| Pretax Income | 458.90 M | 594.90 M | 468.30 M | 362.40 M | 315.70 M | 269.60 M |
| Tax Provision | 104.90 M | 126.30 M | 100.60 M | 74.90 M | 68.60 M | 59.80 M |
| Net Income | 354.00 M | 468.60 M | 367.70 M | 287.50 M | 247.10 M | 209.80 M |
| EPS (Basic) | 1.83 | 2.40 | 1.94 | 1.49 | 1.28 | 1.09 |
| EPS (Diluted) | 1.83 | 2.39 | 1.94 | 1.49 | 1.28 | 1.09 |
| Shares Outstanding | 193.30 M | 192.80 M | 192.80 M | 192.70 M | 192.70 M | 192.60 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.